TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Acute myeloid leukemia (AML) is classified into favorable-risk, intermediate-risk, and poor-risk subtypes. This study aimed to compare the serum proteomic signatures of the three AML subtypes and identify prognostic biomarkers for AML. Serum samples from patients with favorable-risk (n = 14), interm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Liu, Bei, Wu, Shiwen, Zhao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066874/
https://www.ncbi.nlm.nih.gov/pubmed/37016705
http://dx.doi.org/10.1515/med-2022-0602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066874/
https://www.ncbi.nlm.nih.gov/pubmed/37016705
http://dx.doi.org/10.1515/med-2022-0602

Ejemplares similares